<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:f5411057-8870-475d-a833-07fda75b5776,g:e4e6a471-7fda-493b-ac5a-4fee545b200a,d:f3e5125de1724149a07ad96270ff92cd--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>smmt-20220718</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF80L2ZyYWc6MDdhNmUzZmE3Mzc0NDYzOTk2OWI1NTNhNzQzY2VkNWEvdGFibGU6MDk1NzY0N2RiZjdhNDhjZGJlMDkxODkxMjgxN2ZiNGYvdGFibGVyYW5nZTowOTU3NjQ3ZGJmN2E0OGNkYmUwOTE4OTEyODE3ZmI0Zl8wLTEtMS0xLTg0NzE4_72ada897-40a6-49f1-8a26-162c000e37f3">0001599298</ix:nonNumeric><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF80L2ZyYWc6MDdhNmUzZmE3Mzc0NDYzOTk2OWI1NTNhNzQzY2VkNWEvdGFibGU6MDk1NzY0N2RiZjdhNDhjZGJlMDkxODkxMjgxN2ZiNGYvdGFibGVyYW5nZTowOTU3NjQ3ZGJmN2E0OGNkYmUwOTE4OTEyODE3ZmI0Zl8xLTEtMS0xLTg0NzE4_f2c266d2-cb91-4612-8cb4-6361df51ecb1">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="smmt-20220718.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if3e5125de1724149a07ad96270ff92cd_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTcw_47274a39-c7a1-4aae-aa10-9944b5d6d995">8-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date of Report (Date of Earliest Event Reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMjg_a591587c-49c8-4319-b869-c1c2409fe6d0">July 18, 2022</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="padding-left:5.65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY18wLTAtMS0xLTg0NzE4_84735ab4-2714-4c63-9f10-24b97476d809">Summit Therapeutics Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY18zLTAtMS0xLTg0NzE4_5ce84a0a-374b-4a28-9346-49334338bc11">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY18zLTEtMS0xLTg0NzE4_69161ff9-ad84-4b8a-bccd-9648197303f0">001-36866</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY18zLTItMS0xLTg0NzE4_ccc690bb-b7d7-491b-8c1c-4d77cbe0b9d0">37-1979717</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Commission<br/>File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(IRS Employer<br/>Identification No.)</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY182LTAtMS0xLTg0NzE4L3RleHRyZWdpb246Y2JhOTJjYTY0YzA1NGNkZWE5ZWM3YzFkOTA2YjA5MTFfNQ_02387422-1349-4499-b01d-da46abd78bab">2882 Sand Hill Road, Suite 106</ix:nonNumeric>, <ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY182LTAtMS0xLTg0NzE4L3RleHRyZWdpb246Y2JhOTJjYTY0YzA1NGNkZWE5ZWM3YzFkOTA2YjA5MTFfOQ_798d9c61-6d82-475d-9bd1-aa0489eac086">Menlo Park</ix:nonNumeric>, <ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY182LTAtMS0xLTg0NzE4L3RleHRyZWdpb246Y2JhOTJjYTY0YzA1NGNkZWE5ZWM3YzFkOTA2YjA5MTFfMTM_65796b7a-4534-4cc5-af38-05b7419f9426">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6NzZjOGYwNjEwM2U2NGZjNzhmZWRiNDU4NzYzM2VkY2MvdGFibGVyYW5nZTo3NmM4ZjA2MTAzZTY0ZmM3OGZlZGI0NTg3NjMzZWRjY182LTItMS0xLTg0NzE4_e42d2466-434a-4229-b371-1dce03162962">94025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Zip Code)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Registrant&#8217;s Telephone Number, Including Area Code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yODk_49fb4c7a-ba7b-4c5b-94ee-645a4db46998">617</ix:nonNumeric>-<ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTY1_3c97fe7f-1fff-4f49-982f-fde74b0d3f47">514-7149</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="padding-left:5.65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Not applicable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Former Name or Former Address, If Changed Since Last Report)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTcx_cf48aa6b-76a2-4ca7-8e27-8b7ea35ccbcb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTY3_b6e28391-18c5-440f-8dcf-c76965b9d834">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTY4_d877ca26-3699-4924-89b2-f498d3155878">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTY5_05b8b930-e579-4fa5-a132-e3e106385234">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:6.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6YjNhODIxYTZiNWU4NGJjOTlhM2I2MjYzZmNlN2ZlMTQvdGFibGVyYW5nZTpiM2E4MjFhNmI1ZTg0YmM5OWEzYjYyNjNmY2U3ZmUxNF8xLTAtMS0xLTg0NzE4_d4355ec1-0829-4879-a982-553a69a66989">Common stock, $0.01&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6YjNhODIxYTZiNWU4NGJjOTlhM2I2MjYzZmNlN2ZlMTQvdGFibGVyYW5nZTpiM2E4MjFhNmI1ZTg0YmM5OWEzYjYyNjNmY2U3ZmUxNF8xLTEtMS0xLTg0NzE4_10374198-82bb-4b27-aeff-d8a4b89390a6">SMMT</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGFibGU6YjNhODIxYTZiNWU4NGJjOTlhM2I2MjYzZmNlN2ZlMTQvdGFibGVyYW5nZTpiM2E4MjFhNmI1ZTg0YmM5OWEzYjYyNjNmY2U3ZmUxNF8xLTItMS0xLTg0NzE4_2d30633d-3fe0-43ac-9857-7b5c42b778b1">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6e438ab24ee4448f833036e6302b6b32_D20220718-20220718" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzZTUxMjVkZTE3MjQxNDlhMDdhZDk2MjcwZmY5MmNkL3NlYzpmM2U1MTI1ZGUxNzI0MTQ5YTA3YWQ5NjI3MGZmOTJjZF8xL2ZyYWc6ZjgwMmVmNGUyOTQzNGZkOTgyZjdkZTc2ZGRkZDY2M2QvdGV4dHJlZ2lvbjpmODAyZWY0ZTI5NDM0ZmQ5ODJmN2RlNzZkZGRkNjYzZF8yMTc1_21e61fea-23ed-4b80-a9d3-924acd338c92">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Events. </span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 18, 2022, Summit Therapeutics Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) issued a press release announcing the commencement of its previously-announced rights offering pursuant to a shelf registration statement filed on Form S-3 (File No. 333-249316) (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Registration Statement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) with the Securities and Exchange Commission, which was declared effective October 15, 2020, and the prospectus supplement relating to the rights offering filed with the SEC on July 18, 2022 (the prospectus supplement together with the accompanying prospectus, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Prospectus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the rights offering, the Company is filing certain ancillary documents as Exhibits 4.1, 99.1, 99.2, 99.3, 99.4, 99.5, 99.6, and 99.7 to this Current Report on Form 8-K for the purpose of incorporating such items by reference to the Registration Statement, of which the Prospectus forms a part. The Company is also filing as Exhibit 5.1 the opinion of Baker &amp; Hostetler LLP in connection with the issuance of the subscription rights and the shares of the Company&#8217;s common stock, par value $0.01 per share (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), issuable upon exercise of such subscription rights.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor will there be any sale of such securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The rights offering will be made only by means of the Prospectus, copies of which will be mailed to all record holders entitled to participate in the rights offering, and can be accessed through the SEC&#8217;s website at www.sec.gov. A copy of the Prospectus may also be obtained by contacting the information agent for the rights offering, Broadridge Corporate Issuer Solutions, Inc., at (855) 793-5068.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">A copy of the press release related to the matters set forth herein is attached hereto as Exhibit 99.7 and is incorporated herein by reference. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8239; </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.743%"><tr><td style="width:1.0%"></td><td style="width:22.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statements and Exhibits.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits</span></div><div><span><br/></span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3pt;padding-right:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-subscriptionrightscer.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-subscriptionrightscer.htm">Form of Subscription Rights Certificate</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-ex51xbhlegalopinion.htm">5.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-ex51xbhlegalopinion.htm">Legal Opinion of Baker &amp; Hostetler LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-ex232xbhlegalopinion.htm">23.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-ex232xbhlegalopinion.htm">Consent of Baker &amp; Hostetler LLP (included in Exhibit 5.1 hereto)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-instructionformjuly20.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-instructionformjuly20.htm">Form of Instructions For Use of Non-Transferable Subscription Rights Certificates</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-formoflettertostockho.htm">99.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-formoflettertostockho.htm">Form of Letter to Stockholders who are Record Holders</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-formoflettertobrokers.htm">99.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-formoflettertobrokers.htm">Form of Letter to Brokers and other Nominee Holders</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-formoflettertoclients.htm">99.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-formoflettertoclients.htm">Form of Letter to Clients of Brokers and other Nominee Holders</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-formofnomineeholderce.htm">99.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-formofnomineeholderce.htm">Form of Nominee Holder Certification</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="smmt-xbeneficialownerelect.htm">99.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="smmt-xbeneficialownerelect.htm">Form of Beneficial Owner Election Form</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a2022_prx0718xcommencement.htm">99.7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="a2022_prx0718xcommencement.htm">Press Release, dated July 18, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</span></div><div style="padding-left:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SUMMIT THERAPEUTICS&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: July 18, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ Ankur Dhingra</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "smmt-20220718.htm", "description": "8-K", "secsgml_size_bytes": 49276}]
{"company-data": {"conformed-name": "Summit Therapeutics Inc.", "cik": "0001599298", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36866", "film-number": "221089370"}, "business-address": {"street1": "2882 SAND HILL ROAD", "street2": "SUITE 106", "city": "MENLO PARK", "state": "CA", "zip": "94025", "phone": "617-514-7149"}, "mail-address": {"street1": "2882 SAND HILL ROAD", "street2": "SUITE 106", "city": "MENLO PARK", "state": "CA", "zip": "94025"}, "former-company": [{"former-conformed-name": "Summit Therapeutics plc", "date-changed": "20150219"}, {"former-conformed-name": "Summit Corp plc", "date-changed": "20140205"}]}
smmt-20220718
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
July 18, 2022
Summit Therapeutics Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
001-36866
37-1979717
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
2882 Sand Hill Road, Suite 106
,
Menlo Park
,
CA
94025
(Address of Principal Executive Offices)
(Zip Code)
Registrant's Telephone Number, Including Area Code:
617
-
514-7149
Not applicable
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common stock, $0.01 par value per share
SMMT
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 8.01
Other Events.
On July 18, 2022, Summit Therapeutics Inc. (the "
Company
") issued a press release announcing the commencement of its previously-announced rights offering pursuant to a shelf registration statement filed on Form S-3 (File No. 333-249316) (the "
Registration Statement
") with the Securities and Exchange Commission, which was declared effective October 15, 2020, and the prospectus supplement relating to the rights offering filed with the SEC on July 18, 2022 (the prospectus supplement together with the accompanying prospectus, the "
Prospectus
").
In connection with the rights offering, the Company is filing certain ancillary documents as Exhibits 4.1, 99.1, 99.2, 99.3, 99.4, 99.5, 99.6, and 99.7 to this Current Report on Form 8-K for the purpose of incorporating such items by reference to the Registration Statement, of which the Prospectus forms a part. The Company is also filing as Exhibit 5.1 the opinion of Baker & Hostetler LLP in connection with the issuance of the subscription rights and the shares of the Company's common stock, par value $0.01 per share ("
Common Stock
"), issuable upon exercise of such subscription rights.
This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor will there be any sale of such securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The rights offering will be made only by means of the Prospectus, copies of which will be mailed to all record holders entitled to participate in the rights offering, and can be accessed through the SEC's website at www.sec.gov. A copy of the Prospectus may also be obtained by contacting the information agent for the rights offering, Broadridge Corporate Issuer Solutions, Inc., at (855) 793-5068.
A copy of the press release related to the matters set forth herein is attached hereto as Exhibit 99.7 and is incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Description
4.1
Form of Subscription Rights Certificate
5.1
Legal Opinion of Baker & Hostetler LLP
23.2
Consent of Baker & Hostetler LLP (included in Exhibit 5.1 hereto)
99.1
Form of Instructions For Use of Non-Transferable Subscription Rights Certificates
99.2
Form of Letter to Stockholders who are Record Holders
99.3
Form of Letter to Brokers and other Nominee Holders
99.4
Form of Letter to Clients of Brokers and other Nominee Holders
99.5
Form of Nominee Holder Certification
99.6
Form of Beneficial Owner Election Form
99.7
Press Release, dated July 18, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
SUMMIT THERAPEUTICS INC.
Date: July 18, 2022
By:
/s/ Ankur Dhingra
Chief Financial Officer